ALXN1007

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ALXN1007, covering 2014-03-31 to 2017-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease [Phase 2]

See pricing